These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38102465)

  • 1. m6A reader IGF2BP2 promotes lymphatic metastasis by stabilizing DPP4 in papillary thyroid carcinoma.
    Wang W; Ding Y; Zhao Y; Li X
    Cancer Gene Ther; 2024 Feb; 31(2):285-299. PubMed ID: 38102465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
    Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTO/IGF2BP2-mediated N6 methyladenosine modification in invasion and metastasis of thyroid carcinoma via CDH12.
    Chen Z; Zhong X; Xia M; Liu C; Tang W; Liu G; Yi Y; Guo Y; Jiang Q; Zu X; Zhong J
    Cell Death Dis; 2024 Oct; 15(10):733. PubMed ID: 39379360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The m6A reader IGF2BP2 promotes the progression of esophageal squamous cell carcinoma cells by increasing the stability of OCT4 mRNA.
    Zhao R; Li T; Zhao X; Yang Z; Ma L; Wang X
    Biochem Cell Biol; 2024 Apr; 102(2):169-178. PubMed ID: 37917979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF2BP2 knockdown suppresses thyroid cancer progression by reducing the expression of long non-coding RNA HAGLR.
    Dong L; Geng Z; Liu Z; Tao M; Pan M; Lu X
    Pathol Res Pract; 2021 Sep; 225():153550. PubMed ID: 34340128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FosB recruits KAT5 to potentiate the growth and metastasis of papillary thyroid cancer in a DPP4-dependent manner.
    Du J; Fu L; Ji F; Wang C; Liu S; Qiu X
    Life Sci; 2020 Oct; 259():118374. PubMed ID: 32891613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DPP4 gene silencing inhibits proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through suppression of the MAPK pathway.
    Hu X; Chen S; Xie C; Li Z; Wu Z; You Z
    J Endocrinol Invest; 2021 Aug; 44(8):1609-1623. PubMed ID: 33387351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
    Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
    J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL3-mediated m6A modification of STEAP2 mRNA inhibits papillary thyroid cancer progress by blocking the Hedgehog signaling pathway and epithelial-to-mesenchymal transition.
    Zhu Y; Peng X; Zhou Q; Tan L; Zhang C; Lin S; Long M
    Cell Death Dis; 2022 Apr; 13(4):358. PubMed ID: 35436987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting IGF2BP2 Promotes Differentiation of Radioiodine Refractory Papillary Thyroid Cancer via Destabilizing RUNX2 mRNA.
    Sa R; Liang R; Qiu X; He Z; Liu Z; Chen L
    Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpressed ZC3H13 suppresses papillary thyroid carcinoma growth through m6A modification-mediated IQGAP1 degradation.
    Xie R; Chen W; Lv Y; Xu D; Huang D; Zhou T; Zhang S; Xiong C; Yu J
    J Formos Med Assoc; 2023 Aug; 122(8):738-746. PubMed ID: 36739231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatic identification reveals a m6A-binding protein, IGF2BP2, as a novel tumor-promoting gene signature in thyroid carcinoma.
    Xie Y; Xiao J; Ying Y; Liu J; Zhang L; Zeng X
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Aug; 397(8):5663-5676. PubMed ID: 38289368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipeptidyl Peptidase-4 Stabilizes Integrin α4β1 Complex to Promote Thyroid Cancer Cell Metastasis by Activating Transforming Growth Factor-Beta Signaling Pathway.
    He Q; Cao H; Zhao Y; Chen P; Wang N; Li W; Cui R; Hou P; Zhang X; Ji M
    Thyroid; 2022 Nov; 32(11):1411-1422. PubMed ID: 36166219
    [No Abstract]   [Full Text] [Related]  

  • 14. METTL14 Facilitates the Metastasis of Pancreatic Carcinoma by Stabilizing LINC00941 in an m6A-IGF2BP2-Dependent Manner.
    Lu J; Yu L; Xie N; Wu Y; Li B
    J Cancer; 2023; 14(7):1117-1131. PubMed ID: 37215454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis.
    Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B
    Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner.
    Wang X; Lu X; Wang P; Chen Q; Xiong L; Tang M; Hong C; Lin X; Shi K; Liang L; Lin J
    J Transl Med; 2022 May; 20(1):198. PubMed ID: 35509101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic Ras/squamous cell carcinoma antigen signaling pathway activation promotes invasiveness and lymph node metastases in papillary thyroid carcinoma.
    Luo D; Liu Y; Lin S; Tan L; Du Z; Long M; Zhu Y; Peng X; Zong W; Mackenzie GG; Li H; Ouyang N
    Oncol Rep; 2019 Feb; 41(2):1253-1263. PubMed ID: 30535496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropilin-2 promotes growth and progression of papillary thyroid cancer cells.
    Lee G; Kang YE; Oh C; Liu L; Jin Y; Lim MA; Won HR; Chang JW; Koo BS
    Auris Nasus Larynx; 2020 Oct; 47(5):870-880. PubMed ID: 32381353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. m6A Writer METTL3-Mediated lncRNA LINC01125 Prevents the Malignancy of Papillary Thyroid Cancer.
    He T; Xia H; Chen B; Duan Z; Huang C
    Crit Rev Immunol; 2023; 43(3):43-53. PubMed ID: 37824376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CircCDK1 blocking IGF2BP2-mediated m6A modification of CPPED1 promotes laryngeal squamous cell carcinoma metastasis via the PI3K/AKT signal pathway.
    Li J; Cao H; Yang J; Wang B
    Gene; 2023 Oct; 884():147686. PubMed ID: 37543219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.